$POAI
Predictive Oncology Inc. Stock $poai

$poai Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000117184319005561 Filed on August 19, 2019

Income Statement

Concept	2019 Q2	2018 Q2	2018 Q1
Revenue	$286.2K	$358.6K	$411.6K
YoY Change	-20.2%	235.69%	134.97%
Cost Of Revenue	$118.4K	$109.0K	$117.3K
YoY Change	8.64%	395.09%	217.21%
Gross Profit	$167.8K	$249.6K	$294.3K
YoY Change	-32.79%	194.32%	112.96%
Gross Profit Margin	58.63%	69.61%	71.49%
Selling, General & Admin	$3.995M	$1.284M	$1.792M
YoY Change	211.26%	-47.52%	40.09%
% of Gross Profit	2381.6%	514.23%	609.18%
Research & Development			$94.01K
YoY Change			11.29%
% of Gross Profit			31.95%
Depreciation & Amortization	$131.4K	$18.83K	$18.17K
YoY Change	598.11%	29.66%	-2.19%
% of Gross Profit	78.34%	7.54%	6.17%
Operating Expenses	$3.995M	$1.284M	$1.786M
YoY Change	211.26%	-48.98%	30.93%
Operating Profit	-$5.099M	-$1.413M	-$1.492M
YoY Change	260.88%	-41.88%	21.68%
Interest Expense	$6.160M	-$960.0K
YoY Change	-741.67%
% of Operating Profit
Other Income/Expense, Net	-$819.3K
YoY Change
Pretax Income	$1.470M	-$2.370M	-$1.760M
YoY Change	-162.03%	-6.69%	31.34%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	$1.465M	-$2.373M	-$1.760M
YoY Change	-161.73%	-6.56%	31.34%
Net Earnings / Revenue	512.0%	-661.88%	-427.61%
Basic Earnings Per Share	$0.49	-$0.20
Diluted Earnings Per Share	$0.24	-$0.20	-$1.544M
COMMON SHARES
Basic Shares Outstanding	2.961M	11.88M	11.38M
Diluted Shares Outstanding	6.007M	11.88M	11.38M

Balance Sheet

Concept	2019 Q2	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.00K	$1.000M	$2.230M
YoY Change	-93.0%	-74.03%	-53.35%
Cash & Equivalents	$69.56K	$1.004M	$2.233M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$150.0K	$280.0K	$210.0K
YoY Change	-46.43%	47.37%	31.25%
Inventory	$320.9K	$244.7K	$272.6K
Prepaid Expenses
Receivables	$299.0K	$315.3K	$241.8K
Other Receivables	$250.0K	$160.0K	$170.0K
Total Short-Term Assets	$1.094M	$2.007M	$3.123M
YoY Change	-45.5%	-53.63%	-40.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.770M	$184.4K	$106.0K
YoY Change	859.85%	67.73%	-5.94%
Goodwill	$23.79M
YoY Change
Intangibles	$4.592M	$115.1K	$115.7K
YoY Change	3888.11%	23.4%	21.58%
Long-Term Investments		$581.7K	$1.542M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$31.16M	$1.994M	$2.876M
YoY Change	1462.73%	881.03%	1283.72%
TOTAL ASSETS
Total Short-Term Assets	$1.094M	$2.007M	$3.123M
Total Long-Term Assets	$31.16M	$1.994M	$2.876M
Total Assets	$32.25M	$4.001M	$5.999M
YoY Change	706.08%	-11.72%	9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.539M	$165.6K	$186.3K
YoY Change	2037.13%	188.35%	135.05%
Accrued Expenses	$1.036M	$455.3K	$558.4K
YoY Change	127.42%	-61.53%	-53.58%
Deferred Revenue	$29.71K	$18.34K	$38.86K
YoY Change	61.96%
Short-Term Debt	$3.810M	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.456M	$640.0K	$780.0K
YoY Change	1377.47%	-49.01%	-39.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$500.0K
YoY Change
Total Long-Term Liabilities	$500.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.456M	$640.0K	$780.0K
Total Long-Term Liabilities	$500.0K	$0.00	$0.00
Total Liabilities	$9.960M	$639.3K	$783.6K
YoY Change	1458.05%	-52.03%	-47.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.94M	-$58.90M	-$56.53M
YoY Change	10.25%	15.71%	16.88%
Common Stock	$309.7K	$120.9K	$118.0K
YoY Change	156.22%	95.32%	81.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.29M	$3.362M	$5.216M
YoY Change
Total Liabilities & Shareholders Equity	$32.25M	$4.001M	$5.999M
YoY Change	706.08%	-11.72%	9.75%

Cashflow Statement

Concept	2019 Q2	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	$1.465M	-$2.373M	-$1.760M
YoY Change	-161.73%	-6.56%	31.34%
Depreciation, Depletion And Amortization	$131.4K	$18.83K	$18.17K
YoY Change	598.11%	29.66%	-2.19%
Cash From Operating Activities	-$2.000M	-$1.420M	-$1.694M
YoY Change	40.85%	56.04%	46.54%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$100.0K	$32.79K
YoY Change	-90.0%	900.0%	21.9%
Acquisitions
YoY Change
Other Investing Activities	$50.00K	$0.00	$200.0K
YoY Change			-108.66%
Cash From Investing Activities	$40.00K	-$110.0K	$145.6K
YoY Change	-136.36%	1000.0%	-106.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.960M
YoY Change			-22.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	890.0K	280.0K	3.015M
YoY Change	217.86%		-20.96%
NET CHANGE
Cash From Operating Activities	-2.000M	-1.420M	-1.694M
Cash From Investing Activities	40.00K	-110.0K	145.6K
Cash From Financing Activities	890.0K	280.0K	3.015M
Net Change In Cash	-1.070M	-1.250M	1.467M
YoY Change	-14.4%	35.87%	355.02%
FREE CASH FLOW
Cash From Operating Activities	-$2.000M	-$1.420M	-$1.694M
Capital Expenditures	-$10.00K	-$100.0K	$32.79K
Free Cash Flow	-$1.990M	-$1.320M	-$1.727M
YoY Change	50.76%	46.67%	45.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Registrant Name EntityRegistrantName	Predictive Oncology Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001446159
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	poai
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	poai	Consideration For Extinguishment Of Debt ConsiderationForExtinguishmentOfDebt	26711791
	poai	Consideration For Extinguishment Of Debt ConsiderationForExtinguishmentOfDebt	1542250
	poai	Derivative Liabilities Increase Due To Issuance Of Warrants DerivativeLiabilitiesIncreaseDueToIssuanceOfWarrants	69722
	poai	Forebearanace Settlement On Bridge Loan ForebearanaceSettlementOnBridgeLoan	503009
	poai	Forebearanace Settlement On Bridge Loan ForebearanaceSettlementOnBridgeLoan
	poai	Gain Loss On Revaluation Of Equity Method Investment GainLossOnRevaluationOfEquityMethodInvestment	6164260
	poai	Gain Loss On Revaluation Of Equity Method Investment GainLossOnRevaluationOfEquityMethodInvestment
CY2019Q2	poai	Gain Loss On Revaluation Of Equity Method Investment GainLossOnRevaluationOfEquityMethodInvestment	6164260
CY2018Q2	poai	Gain Loss On Revaluation Of Equity Method Investment GainLossOnRevaluationOfEquityMethodInvestment
	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation	1222244
	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation
CY2019Q2	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation	1222244
CY2018Q2	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation
	poai	Maintenance Plan Service Requirement Period Subsequent To One Year Anniversary Of Invoice MaintenancePlanServiceRequirementPeriodSubsequentToOneYearAnniversaryOfInvoice	P1Y
	poai	Proceeds From Redemption Of Certificates Of Deposits ProceedsFromRedemptionOfCertificatesOfDeposits
	poai	Proceeds From Redemption Of Certificates Of Deposits ProceedsFromRedemptionOfCertificatesOfDeposits	244971
	poai	Standard Product Warranty Term StandardProductWarrantyTerm	P1Y
CY2019Q2	poai	Stock Issued During Period Value Convertible Preferred Shares Issued StockIssuedDuringPeriodValueConvertiblePreferredSharesIssued	743560
CY2019Q2	poai	Stock Issued During Period Value Extinguishment Of Debt StockIssuedDuringPeriodValueExtinguishmentOfDebt	6463309
	poai	Stock Issued During Period Value Extinguishment Of Debt StockIssuedDuringPeriodValueExtinguishmentOfDebt	6463309
	poai	Stock Issued During Period Value Forebearance For Bridge Loan StockIssuedDuringPeriodValueForebearanceForBridgeLoan	158349
CY2019Q2	poai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	5786
	poai	Warrants Issued WarrantsIssued	32215
	poai	Warrants Issued WarrantsIssued
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3538832
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	445689
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	299046
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	232602
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1035501
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1279114
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	512067
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	358765
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86882073
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63019708
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	233982
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1380620
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	460368
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1644220
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1380620
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1644220
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	233981
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	460368
CY2019Q2	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	787524
CY2018Q4	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	787524
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1068256
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	88416
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106060
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4070
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7741
CY2019Q2	us-gaap	Assets Assets	32251502
CY2018Q4	us-gaap	Assets Assets	3708999
CY2019Q2	us-gaap	Assets Current AssetsCurrent	1094002
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1451527
CY2019Q2	us-gaap	Assets Net AssetsNet	22291588
CY2018Q4	us-gaap	Assets Net AssetsNet	53472
CY2019Q2	us-gaap	Bridge Loan BridgeLoan	3808751
CY2018Q4	us-gaap	Bridge Loan BridgeLoan	1634914
CY2019Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1399809
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3240611
CY2019Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	286376
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	587452
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	248102
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69557
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	162152
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	162152
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	766189
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69557
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1004269
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92595
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	238080
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30974761
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14091748
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	309747
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	140917
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1444706
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2373410
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1848478
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4133432
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Credit Risk </div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> financial institution. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> credit risk concentration for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</div></div></div></div></div></div></div></div>
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29706
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23065
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	6479
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	118390
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	108970
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	192106
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	226314
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	238573
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2019Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	573155
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1032814
CY2019Q2	us-gaap	Depreciation Depreciation	131420
	us-gaap	Depreciation Depreciation	153302
CY2018Q2	us-gaap	Depreciation Depreciation	18825
	us-gaap	Depreciation Depreciation	33321
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	259362
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41062
CY2019Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	541599
CY2018Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	272745
	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	231347
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	32215
CY2018Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	272745
CY2019Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	541599
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	723870
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	231348
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	337368
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	231308
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3203356
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	181748
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	215165
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	264609
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	363497
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	363497
CY2019Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4929240
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1195803
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4591872
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	964495
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3310368
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	729528
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4808314
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1945670
CY2019Q2	us-gaap	Goodwill Goodwill	23790290
CY2018Q4	us-gaap	Goodwill Goodwill
CY2019Q2	us-gaap	Inventory Net InventoryNet	320876
CY2018Q4	us-gaap	Inventory Net InventoryNet	241066
CY2019Q2	us-gaap	Gross Profit GrossProfit	167761
CY2018Q2	us-gaap	Gross Profit GrossProfit	249616
	us-gaap	Gross Profit GrossProfit	349286
	us-gaap	Gross Profit GrossProfit	543865
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-439637
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-960508
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-960508
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	718483
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	25126
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-141325
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177828
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-104114
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-329889
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6641
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11679
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	55665
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20385
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	975000
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	42524
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-66989
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-14490
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	30461410
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4591872
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	964495
	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	42746
	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	150340
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	58701
CY2019Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	79099
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	55362
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	127003
CY2019Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	91437
CY2019Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	153923
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	183135
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	19936
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	37179
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1145263
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	157932
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	44271
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	43403
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	118976
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	520981
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	259700
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	139738
CY2019Q2	us-gaap	Liabilities Liabilities	9959914
CY2018Q4	us-gaap	Liabilities Liabilities	3655527
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32251502
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3708999
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9455816
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3655527
CY2019Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4533813
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3300678
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-580913
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44933
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4045495
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3107531
	us-gaap	Net Income Loss NetIncomeLoss	-1828080
	us-gaap	Net Income Loss NetIncomeLoss	-4133432
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1465104
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-2373410
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1444706
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2373410
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1848478
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4133432
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-819283
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1389059
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense
CY2019Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000
CY2018Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	497276
CY2019Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent
CY2018Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1112524
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5
	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017 2018
CY2019Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1271258
CY2018Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	378906
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1737824
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	666496
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5098894
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1412902
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7436097
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3172924
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1005525
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	501427
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	504098
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1005525
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y69D
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3223
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	50209
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8433
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	27524
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	129990
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	154523
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	318431
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2479708
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2959509
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	743560
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1525000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	154418
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5786
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	341169
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2281880
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	539218
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1769813
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	180453
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	795353
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses
	us-gaap	Repayments Of Debt RepaymentsOfDebt	220241
	us-gaap	Repayments Of Debt RepaymentsOfDebt
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64936025
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63107945
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	286151
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	358586
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	541392
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	770179
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	685029
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	554084
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1239245
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1104623
	us-gaap	Share Based Compensation ShareBasedCompensation	1644220
	us-gaap	Share Based Compensation ShareBasedCompensation	460368
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.786
CY2019Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5612250
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5612250
CY2019Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	148571
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2755087
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	5215833
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	3361778
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	70005
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	22291588
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2691913
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	53472
CY2019Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	20398
CY2018Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	20398
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60070783
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11878490
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22747544
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11632221
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29609373
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11878490
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22747544
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11632221

Files In Submission

Name	View Source	Status
0001171843-19-005561-index-headers.html	Edgar Link	pending
0001171843-19-005561-index.html	Edgar Link	pending
0001171843-19-005561.txt	Edgar Link	pending
0001171843-19-005561-xbrl.zip	Edgar Link	pending
exh102_01.jpg	Edgar Link	pending
exh102_02.jpg	Edgar Link	pending
exh103_01.jpg	Edgar Link	pending
exh103_02.jpg	Edgar Link	pending
exh103_03.jpg	Edgar Link	pending
exh_102.htm	Edgar Link	pending
exh_103.htm	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
f10q_081419p.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
poai-20190630.xml	Edgar Link	completed
poai-20190630.xsd	Edgar Link	pending
poai-20190630_cal.xml	Edgar Link	unprocessable
poai-20190630_def.xml	Edgar Link	unprocessable
poai-20190630_lab.xml	Edgar Link	unprocessable
poai-20190630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POAI
Predictive Oncology Inc. Stock $poai

2019 Q2 Form 10-Q Financial Statement

#000117184319005561 Filed on August 19, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI Predictive Oncology Inc. Stock $poai

2019 Q2 Form 10-Q Financial Statement

#000117184319005561 Filed on August 19, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI
Predictive Oncology Inc. Stock $poai